Lipid Nanoparticles for In Vivo Lung Delivery of CRISPR-Cas9 Ribonucleoproteins Allow Gene Editing of Clinical Targets
ACS Nano · 15.04.2025 · 19 (14) · 13790-13804
DOI: 10.1021/acsnano.4c16617 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, online erschienen am 04.04.2025. Verfasst von Rebecca M Haley und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States. Hauptthemen laut MEDLINE: Gene Editing, CRISPR-Cas Systems, Ribonucleoproteins, Lung. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: NCI NIH HHS, NIDCR NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Bioengineering, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States.
- Raymond G. Perelman Center for Cellular and Molecular Therapeutics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104, United States.
- Cell and Molecular Biology Graduate Group, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States.
- Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States.
- Penn Institute for RNA Innovation, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States.
ORCID-Profile: Rebecca M Haley, Marshall S Padilla, Ryann A Joseph, Christian G Figueroa-Espada, Rohan Palanki, Michael J Mitchell
Förderung
- NCI NIH HHS
- NIDCR NIH HHS
- NHLBI NIH HHS
- NCATS NIH HHS
- NIGMS NIH HHS
- National Center for Advancing Translational Sciences
- National Science Foundation Graduate Research Fellowship Program
- National Cancer Institute
Zitieren
APA
Haley, R. M., Padilla, M. S., El-Mayta, R. D., Joseph, R. A., Weber, J. A., Figueroa-Espada, C. G., Mukalel, A. J., Ricciardi, A. S., Palanki, R., Geisler, H. C., Jester, M. T., Davidson, B. L., & Mitchell, M. J. (2025). Lipid Nanoparticles for In Vivo Lung Delivery of CRISPR-Cas9 Ribonucleoproteins Allow Gene Editing of Clinical Targets. ACS Nano, 19(14), 13790-13804. https://doi.org/10.1021/acsnano.4c16617
Vancouver
Haley RM, Padilla MS, El-Mayta RD, Joseph RA, Weber JA, Figueroa-Espada CG, et al. Lipid Nanoparticles for In Vivo Lung Delivery of CRISPR-Cas9 Ribonucleoproteins Allow Gene Editing of Clinical Targets. ACS Nano. 2025;19(14):13790-13804. doi:10.1021/acsnano.4c16617
BibTeX
@article{Haley2025,
author = {Haley, Rebecca M and Padilla, Marshall S and El-Mayta, Rakan D and Joseph, Ryann A and Weber, Jesse A and Figueroa-Espada, Christian G and Mukalel, Alvin J and Ricciardi, Adele S and Palanki, Rohan and Geisler, Hannah C and Jester, Matthew T and Davidson, Beverly L and Mitchell, Michael J},
title = {Lipid Nanoparticles for In Vivo Lung Delivery of CRISPR-Cas9 Ribonucleoproteins Allow Gene Editing of Clinical Targets},
journal = {ACS Nano},
year = {2025},
volume = {19},
number = {14},
pages = {13790--13804},
doi = {10.1021/acsnano.4c16617}
}
EUVIMED